Selecting the right private label manufacturing biotech partner is a fundamental aspect of any product’s success on the market. This is why a large number of our clients establish long-term OEM ...

Legend Biotech Corporation (NASDAQ ... dollar total sales for each product before the end of the decade. Label expansion in earlier line diseases is being worked out through a number of trials ...

Phathom Pharmaceuticals (NASDAQ:PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a ...

It was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updates from a few players were in focus. Vertex and CRISPR collaborated in 2015 to focus on the use of ...

If implemented, says Val Giddings, vice president of food and agriculture at the US Biotechnology Industry Organization (Washington, DC), the proposals will “further erode consumer confidence in ...